Shree Ganesh Remedies Ltd is Rated Sell

Current Rating and Its Significance

MarketsMOJO currently assigns a 'Sell' rating to Shree Ganesh Remedies Ltd, indicating a cautious stance for investors. This rating suggests that the stock may underperform relative to the broader market or its sector peers in the near to medium term. Investors are advised to consider this recommendation carefully, balancing it against their portfolio objectives and risk tolerance.

Quality Assessment

As of 15 May 2026, Shree Ganesh Remedies Ltd holds an average quality grade. The company’s operating profit has grown at an annualised rate of 18.27% over the past five years, which reflects moderate growth but falls short of robust expansion seen in higher-quality pharmaceutical peers. Additionally, the latest six-month profit after tax (PAT) stands at ₹9.36 crores, showing a decline of 22.06%, signalling challenges in maintaining profitability momentum.

Valuation Perspective

The stock is currently considered expensive, with a price-to-book (P/B) ratio of 4.2. This valuation is high relative to its return on equity (ROE) of 11.8%, suggesting that investors are paying a premium for the company’s equity despite modest returns. While the stock trades at a discount compared to some peers’ historical valuations, the elevated P/B ratio indicates limited margin of safety for new investors, especially given the recent profit contraction.

Financial Trend Analysis

The financial trend for Shree Ganesh Remedies Ltd is flat, reflecting stagnation in key performance indicators. The company’s profits have fallen by 37.7% over the past year, a significant decline that has contributed to the stock’s underperformance. Over the same period, the stock has delivered a negative return of 25.96%, underperforming the broader BSE500 index, which recorded a marginal decline of 0.03%. This divergence highlights the stock’s relative weakness within the market.

Technical Outlook

Technically, the stock is mildly bearish. Despite a strong one-day gain of 7.55% and a year-to-date return of 15.73%, the overall trend remains subdued. The stock’s performance over the last six months shows a 13.27% gain, but this has not been sufficient to offset the longer-term negative momentum. The mild bearish technical grade suggests that investors should exercise caution and monitor price action closely before considering new positions.

Market Participation and Liquidity

Shree Ganesh Remedies Ltd is classified as a microcap company within the Pharmaceuticals & Biotechnology sector. Notably, domestic mutual funds hold no stake in the company, which may reflect limited institutional confidence or concerns about the stock’s valuation and business prospects. Institutional absence can impact liquidity and price stability, factors that investors should weigh when evaluating the stock.

Comparative Performance

Over the past year, the stock has underperformed significantly, delivering a return of -25.96% compared to the near-flat performance of the BSE500 index. This underperformance is compounded by the company’s declining profitability and flat financial trends, reinforcing the rationale behind the current 'Sell' rating.

Implications for Investors

For investors, the 'Sell' rating on Shree Ganesh Remedies Ltd signals caution. The combination of average quality, expensive valuation, flat financial trends, and mildly bearish technicals suggests limited upside potential in the near term. Investors seeking exposure to the Pharmaceuticals & Biotechnology sector may prefer to consider alternatives with stronger fundamentals and more favourable valuations.

Summary of Key Metrics as of 15 May 2026

To summarise, the stock’s key metrics include a Mojo Score of 37.0, reflecting its current 'Sell' grade. The company’s one-day price change was a positive 7.55%, with a one-month gain of 7.95% and a six-month return of 13.27%. However, the one-year return remains negative at -25.96%, underscoring the stock’s recent struggles. The flat financial grade and average quality grade further reinforce the cautious stance.

Conclusion

Shree Ganesh Remedies Ltd’s current 'Sell' rating by MarketsMOJO, last updated on 14 May 2026, is grounded in a comprehensive evaluation of quality, valuation, financial trends, and technical factors. While the stock has shown some short-term gains, the broader picture remains challenging. Investors should carefully assess these factors in the context of their investment goals and consider the stock’s relative underperformance and valuation risks before committing capital.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →